V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10009013 | 10005398 | 1.67 | 108 | Palliative (P) | 2018-09-13 | 2018-09-13 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 10562814 | CISPLATIN |
| 10009014 | 10005405 | 1.66 | 0 | Palliative (P) | 2017-04-19 | 2017-05-21 | Cyclophosphamide High Dose | N | N | 10563223 | METHOTREXATE INTRATHECAL |
| 10009015 | 10005407 | null | 79 | Palliative (P) | 2017-10-15 | 2017-10-22 | Erlotinib | N | null | 10563459 | CAPECITABINE + IRINOTECAN |
| 10009016 | 10007688 | 1.84 | null | Curative (C) | 2020-01-20 | 2020-01-27 | Capecitabine (21days) + Carboplatin | 1 | null | 10075763 | BORTEZOMIB |
| 10009017 | 10005415 | 1.73 | 66 | Curative (C) | 2017-12-06 | 2017-12-07 | AML18 PILOT TRIAL | 2 | N | 10222557 | FLAIR TRIAL |
| 10009018 | 10005418 | null | 88.15 | Palliative (P) | 2015-04-26 | 2015-04-29 | BORTEZOMIB + THALIDOMIDE | N | null | 10223520 | CISPLATIN + VINORELBINE + RT |
| 10009019 | 10005433 | 1.77 | 78.5 | Adjuvant (A) | null | 2018-09-29 | Melphalan IV High dose | N | null | 10245324 | CYTARABINE INTRATHECAL |
| 10009020 | 10005435 | 1.69 | null | Palliative (P) | 2018-11-19 | 2018-12-02 | Hydroxycarbamide | N | N | 10245610 | PMITCEBO R |
| 10009021 | 10005443 | null | 49.5 | Palliative (P) | 2018-12-03 | 2018-12-10 | Bortezomib + CYCLOPHOSPHAMIDE | N | Y | 10269868 | HYDROXYCARBAMIDE |
| 10009022 | 10005447 | 1.66 | 80 | Curative (C) | null | 2019-07-23 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | 10271252 | HYDROXYCARBAMIDE |
| 10009023 | 10005453 | 1.77 | 88 | Palliative (P) | 2019-06-16 | 2019-06-16 | Cisplatin + Radiotherapy | N | N | 10282870 | CAPECITABINE + RT |
| 10009024 | 10007708 | 1.79 | null | Palliative (P) | 2020-02-24 | 2020-02-25 | Cetuximab + Radiotherapy Load | 02 | N | 10286675 | AXITINIB |
| 10009025 | 10005459 | null | 79.3 | Palliative (P) | 2017-11-23 | 2018-04-05 | NIVOLUMAB | N | N | 10320395 | VENETOCLAX |
| 10009026 | 10005470 | 1.69 | 110.3 | Disease modification (D) | 2019-03-25 | 2019-04-15 | ECF | 2 | N | 10349347 | VINORELBINE |
| 10009027 | 10005476 | null | 80.6 | Palliative (P) | 2018-06-27 | 2018-07-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | 10369878 | POMALIDOMIDE |
| 10009028 | 10005483 | 1.8 | null | Palliative (P) | 2019-08-20 | 2019-08-20 | Triple Intrathecal | Y | Y | 10374253 | BEXAROTENE |
| 10009029 | 10007721 | 1.6 | 135.1 | null | 2020-04-05 | 2020-05-08 | ECX | 2 | Y | 10401494 | CISPLATIN + FLUOROURACIL |
| 10009030 | 10005501 | 1.75 | 77 | Palliative (P) | 2019-08-03 | 2019-08-31 | Nilotinib | 02 | N | 10420706 | OSIMERTINIB |
| 10009031 | 10005505 | null | null | Neo-adjuvant (N) | 2019-01-12 | 2019-03-17 | CISPLATIN + VINORELBINE | 2 | null | 10421914 | RUXOLITINIB |
| 10009032 | 10005516 | 1.71 | 80.4 | Palliative (P) | 2017-10-28 | 2018-01-06 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 2 | N | 10425028 | CAPECITABINE + GEMCITABINE |
| 10009033 | 10005517 | null | 80 | Disease modification (D) | 2017-02-09 | 2017-05-09 | RIALTO TRIAL | N | N | 10425847 | ARSENIC TRIOXIDE + TRETINOIN |
| 10009034 | 10005521 | 1.71 | 70 | Disease modification (D) | 2018-09-12 | 2019-02-06 | Triple Intrathecal | N | N | 10429009 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 10009035 | 10005523 | 1.69 | 73.6 | Curative (C) | 2018-01-14 | 2018-02-17 | IPILIMUMAB + NIVOLUMAB | N | null | 10430552 | BORTEZOMIB + THALIDOMIDE |
| 10009036 | 10005526 | 1.87 | 84.6 | Curative (C) | 2018-04-15 | 2018-04-16 | Irinotecan | 2 | N | 10435336 | CISPLATIN + GEMCITABINE |
| 10009037 | 10005529 | null | 93.7 | Palliative (P) | 2019-04-19 | 2019-06-14 | Pazopanib | N | N | 10437133 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 10009038 | 10005530 | 1.64 | 94.15 | Neo-adjuvant (N) | 2016-06-17 | 2016-06-18 | REMODLB TRIAL | N | N | 10439991 | MPV |
| 10009039 | 10005532 | 1.76 | 75.8 | Curative (C) | 2018-08-29 | 2018-09-10 | Trifluridine + Tipiracil | N | N | 10440812 | ECX |
| 10009040 | 10007741 | 1.72 | null | Palliative (P) | 2019-04-03 | 2019-08-28 | Cyclophosphamide High Dose | N | N | 10445767 | ENZALUTAMIDE |
| 10009041 | 10005542 | null | 74 | Palliative (P) | 2017-02-08 | 2017-03-27 | PIXANTRONE | 2 | N | 10451037 | DOXORUBICIN + OLARATUMAB |
| 10009042 | 10005551 | 1.61 | 69.8 | Palliative (P) | 2015-10-15 | 2016-03-06 | CYTARABINE | 2 | N | 10466384 | IPILIMUMAB |
| 10009043 | 10007753 | null | 77.3 | Palliative (P) | 2019-03-01 | 2019-03-02 | Irinotecan 14day | 2 | N | 10476489 | IDARUBICIN |
| 10009044 | 10007756 | 1.75 | 70.35 | Curative (C) | null | 2017-10-16 | BEAM | N | N | 10483915 | BOSUTINIB |
| 10009045 | 10005566 | 1.78 | null | Palliative (P) | 2017-06-04 | 2017-06-10 | BLEOMYCIN | 01 | N | 10489253 | BORTEZOMIB |
| 10009046 | 10005575 | 1.59 | 55.7 | Curative (C) | 2019-07-31 | 2019-07-31 | VDT-PACE | N | null | 10505211 | CVD R |
| 10009047 | 10007762 | 1.85 | 70 | Palliative (P) | null | 2018-01-04 | CISPLATIN + RT | N | N | 10506839 | CYTARABINE |
| 10009048 | 10005581 | 1.7 | 82 | Adjuvant (A) | 2019-01-09 | 2019-01-23 | FEC | N | N | 10510766 | DABRAFENIB + TRAMETINIB |
| 10009049 | 10005594 | 1.53 | null | Palliative (P) | 2018-07-30 | 2019-10-08 | Docetaxel + Nintedanib | 02 | null | 10523571 | PERTUZUMAB |
| 10009050 | 10005596 | 1.7 | 88.8 | Palliative (P) | 2017-02-02 | 2017-07-22 | Bexarotene | 02 | N | 10526979 | NIVOLUMAB |
| 10009051 | 10005603 | 1.87 | 83 | Adjuvant (A) | 2018-08-08 | 2018-08-08 | Gefitinib: Cycle 3 only (PAS) | 02 | Y | 10543270 | TEMOZOLOMIDE + RT |
| 10009052 | 10007778 | 0 | null | Disease modification (D) | 2016-10-27 | 2016-10-30 | Enzalutamide | N | N | 10547653 | CARMUSTINE + THIOTEPA |
| 10009053 | 10005620 | 1.85 | 108 | Curative (C) | 2017-11-07 | 2017-12-26 | CAP + RT | N | N | 10562316 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 10009054 | 10005624 | 1.66 | 60.35 | Palliative (P) | 2019-11-26 | 2019-11-26 | Docetaxel + Nintedanib | null | N | 10233873 | METHOTREXATE INTRATHECAL |
| 10009055 | 10005631 | 1.77 | 0 | Palliative (P) | 2019-01-10 | 2019-02-02 | FLAG + Idarubicin | N | Y | 10330739 | BEXAROTENE |
| 10009056 | 10005635 | 1.75 | 85.4 | Palliative (P) | 2018-11-01 | 2018-11-11 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | 10350333 | IBRUTINIB + RITUXIMAB |
| 10009057 | 10005647 | 1.68 | 86 | Palliative (P) | 2016-06-30 | 2016-07-21 | Cyclophos + Dex + Lenalidomide | N | N | 10530156 | CETUXIMAB + RT |
| 10009058 | 10006926 | 1.65 | 65.3 | Disease modification (D) | null | 2020-08-20 | Rituximab | 2 | N | 10064622 | RITUXIMAB |
| 10009059 | 10003569 | 1.82 | 81.5 | Adjuvant (A) | 2015-09-14 | 2015-09-28 | Rituximab | N | null | 10235097 | RITUXIMAB |
| 10009060 | 10003579 | 1.64 | 93 | Palliative (P) | 2019-01-22 | 2019-06-04 | CHOP R - 21 days | 02 | N | 10242036 | CHOP R |
| 10009061 | 10003605 | 1.75 | 65.6 | Palliative (P) | 2016-07-06 | 2016-09-30 | Trastuzumab Subcutaneous | 2 | N | 10250247 | TRASTUZUMAB |
| 10009062 | 10003611 | 1.83 | 97 | Palliative (P) | 2018-12-04 | 2018-12-04 | FLUOROURACIL + OXALIPLATIN | N | N | 10254888 | OXALIPLATIN + MDG |